allograft rejection

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

109 documents for allograft rejection

- Grants and cooperative agreements; availability, etc.: host disease and allograft rejection; drug and method to prevent and treat,
- FR, June 22, 1998
- Notices
- National Institutes of Health
- Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus Foliaceus treatment with Mycophenolate Mofetil.
... of renal, cardiac and hepatic allograft rejection in adults, and renal transplant rejectio...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 4, April 2011
- 42 CFR 493.1278 - Standard: Histocompatibility.
... protocols for patients at high risk for allograft rejection; and. (iii) The level of testing require...
- Code of Federal Regulations - Title 42: Public Health

- 21 CFR 862.1163 - Cardiac allograft gene expression profiling test system.
... of a low probability of acute cellular rejection (ACR) in heart transplant recipients with stable a...
- Code of Federal Regulations - Title 21: Food and Drugs
- Organ Procurement and Transplantation Network
This notice of proposed rulemaking sets forth the Secretary's proposal to include vascularized composite allografts, described below, within the definition of organs covered by the rules governing the operation of the . The Secretary further proposes a corresponding change to the definition of human organs covered by section 301 of the National Organ Transplant Act of 1984, as amended.

... is necessary to prevent or treat rejection. This immunosuppression has risks, which have been...
- Federal Register Nbr. 76 FR 78216, December 16, 2011
- Proposed rules
- Health and Human Services Department
- LifeCycle Pharma Announces Positive Interim Results of Phase 2 Clinical Trial of LCP-Tacro for the Prevention of Organ Rejection in De Novo Kidney Transplant Patients.
... for the prevention of transplant allograft rejection when used in combination with cyclospori...
- Business Wire
- April 30, 2009
- On the Record / August 18, 2009
>Hires/Promotions/Honors Podiatry Affiliates Dr. David M. Davidson was elected national president of the American Academy of Podiatric Sports Medicine at the national meeting of the American Podiatric Medical Association in Toronto. Davidson also serves as chief of the Podiatry Section of the Department of Orthopedics at The Kaleida Health System and is medical director of The Center for Wound Care and Hyperbaric Medicine at Millard Fillmore Gates Hospital.

... Title: "Method for diagnosis of chronic allograft rejection ". No.: 7,566,443. Inventors: Baddoura, ...
- Buffalo News
- August 18, 2009
- Data on Investigational Drug Belatacept in Kidney Transplant Recipients to Be Presented at 23rd International Congress of The Transplantation Society.
... Squibb for the prophylaxis of organ rejection in adult patients receiving kidney transplants. Th... are the predominate immune mediators of allograft rejection. About Bristol-Myers Squibb . Bristol-My...
- Business Wire
- August 14, 2010
- Wound healing: from basic science to clinical practice and beyond.
... treated Temporary coverage (15-18) Allograft chemically to remove for burns until antigenic epi... Epidermal (3), (4), No fear of rejection 2-3 weeks needed for (14) Grafts and no delay in a...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 4, April 2011
- Argos Therapeutics Presents Transplantation Data for Soluble CD83 Demonstrating its Ability to Induce Immune Tolerance and Suppress Anti-donor Antibody Responses.
... response and prevent chronic kidney allograft rejection in a preclinical model of transplantatio...
- Business Wire
- May 04, 2010